Ocular Hypotensive Efficacy and Safety of the Rho Kinase Inhibitor AR-12286 in Patients With Elevated Intraocular Pressure

被引：0
|
作者：
Williams, R. D. [1 ]
Novack, G. D. [2 ]
van Haarlem, T. [3 ]
Kopczynski, C. [4 ]
机构：
[1] Clin Res Ctr, Louisville, KY USA
[2] PharmaLog Dev Inc, San Rafael, CA USA
[3] Aerie Pharmaceut Inc, Bridgewater, NJ USA
[4] Aerie Pharmaceut Inc, Res Triangle Pk, NC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
intraocular pressure; trabecular meshwork; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1633
引用
收藏
页数：2
相关论文
共 42 条
  • [1] Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension
    Williams, Robert D.
    Novack, Gary D.
    van Haarlem, Thomas
    Kopczynski, Casey
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 152 (05) : 834 - 841
  • [2] Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
    Skaat, Alon
    Jasien, Jessica V.
    Ritch, Robert
    JOURNAL OF GLAUCOMA, 2016, 25 (09) : E807 - E814
  • [3] Ocular hypotensive efficacy, safety and systemic absorption of AR-12286 ophthalmic solution in normal volunteers
    Kopczynski, Casey
    Novack, Gary D.
    Swearingen, Dennis
    van Haarlem, Thomas
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (05) : 567 - 572
  • [4] Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes
    Ren, Ruiyi
    Humphrey, Anne A.
    Kopczynski, Casey
    Gong, Haiyan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (02)
  • [5] The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
    Pakravan, Mohammad
    Beni, Afsaneh Naderi
    Ghahari, Elham
    Varshochian, Reyhaneh
    Yazdani, Shahin
    Esfandiari, Hamed
    Ahmadieh, Hamid
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (06) : e676 - e680
  • [6] Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
    Wu, Jo-Hsuan
    Chang, Sheng-Nan
    Nishida, Takashi
    Kuo, Bo-, I
    Lin, Jou-Wei
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (03) : 937 - 948
  • [7] Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials
    Jo-Hsuan Wu
    Sheng-Nan Chang
    Takashi Nishida
    Bo-I Kuo
    Jou-Wei Lin
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 937 - 948
  • [8] Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated Intraocular pressure
    Dubiner, HB
    Sircy, MD
    Landry, T
    Bergamini, MV
    Silver, LH
    Turner, FD
    Robertson, S
    Andrew, RM
    Weiner, A
    Przydryga, J
    CLINICAL THERAPEUTICS, 2004, 26 (01) : 84 - 91
  • [9] Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)
    Kahook, Malik Y.
    Serle, Janet B.
    Mah, Francis S.
    Kim, Terry
    Raizman, Michael B.
    Heah, Theresa
    Ramirez-Davis, Nancy
    Kopczynski, Casey C.
    Usner, Dale W.
    Novack, Gary D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 200 : 130 - 137
  • [10] Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
    Komizo, Takashi
    Ono, Takashi
    Yagi, Akiko
    Miyata, Kazunori
    Aihara, Makoto
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2019, 63 (01) : 40 - 45
12345